Flow cytometric analysis of human PBMC (human peripheral blood mononuclear cell) labelling CD40 antibody at 1/200 (1 μg) dilution (Right) compared with a Mouse monoclonal IgG isotype control (Left). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD19 - Alexa Fluor® 647 separately. Gated on total viable cells.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD40 |
Synonyms | Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, CDw40, TNFRSF5 |
Location | Secreted, Cell membrane |
Accession | P25942 |
Clone Number | S-R485 |
Antibody Type | Mouse mAb |
Isotype | IgG2b |
Application | FCM |
Reactivity | Hu |
Purification | Protein A |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
application | dilution | species |
FCM | 1:200 | null |
Background
CD40, also known as TNFRSF5, is a type I transmembrane glycoprotein and a member of the tumor necrosis factor receptor superfamily. It is primarily expressed on antigen-presenting cells such as B cells, dendritic cells, and monocytes, and plays a pivotal role in the regulation of immune responses. The interaction of CD40 with its ligand, CD40L (CD154), is crucial for T cell activation, B cell proliferation, and the induction of humoral immunity. CD40 signaling is also involved in the maturation of dendritic cells and the promotion of cell-mediated immunity. Additionally, CD40 has been implicated in the pathogenesis of various cancers and is considered a potential target for immunotherapeutic strategies.
Picture
Picture
FC
